Dihexa is now scheduled for PCAC review before the end of February 2027, alongside four other peptides: LL-37, GHK-Cu, PEG-MGF, and Melanotan II
The CD4+/CD8+ ratio serves as a key marker of immune system aging, with a shift toward CD8+ dominance often linked to chronic inflammation, reduced pathogen defense, and heightened all-cause mortality risk
They support the bodys natural production of glutathione, which can be a gentler and more sustainable approach
Three-dimensional structure of the glutathione synthetase from Escherichia coli B at 2.0 A resolution
Purity, claimed at 99% on the product labels, came in between 7.7% and 14.37% across tested batches